A Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-03882845 In Healthy Volunteers

NCT00971802 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: PF-03882845 or Placebo
DRUG: PF-03882845 or Placebo
DRUG: PF-03882845 or Placebo
DRUG: PF-03882845 or Placebo

Sponsor

Pfizer